These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7561013)

  • 1. Left ventricular mass in hereditary human hypertension: glucocorticoid-suppressible hyperaldosteronism.
    Jamieson A; Murdoch D; Kennedy JA; Connell JM
    J Hypertens; 1995 May; 13(5):551-6. PubMed ID: 7561013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study.
    Gaddam K; Corros C; Pimenta E; Ahmed M; Denney T; Aban I; Inusah S; Gupta H; Lloyd SG; Oparil S; Husain A; Dell'Italia LJ; Calhoun DA
    Hypertension; 2010 May; 55(5):1137-42. PubMed ID: 20351345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-suppressible hyperaldosteronism: effects of crossover site and parental origin of chimaeric gene on phenotypic expression.
    Jamieson A; Slutsker L; Inglis GC; Fraser R; White PC; Connell JM
    Clin Sci (Lond); 1995 May; 88(5):563-70. PubMed ID: 7614815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
    Ori Y; Chagnac A; Korzets A; Zingerman B; Herman-Edelstein M; Bergman M; Gafter U; Salman H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
    Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.
    Lin YH; Lee HH; Liu KL; Lee JK; Shih SR; Chueh SC; Lin WC; Lin LC; Lin LY; Chung SD; Wu VC; Kuo CC; Ho YL; Chen MF; Wu KD;
    Surgery; 2011 Sep; 150(3):526-33. PubMed ID: 21514614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
    Woodland E; Tunny TJ; Hamlet SM; Gordon RD
    Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
    Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA
    Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
    Stowasser M; Gordon RD; Klemm SA; Tunny TJ
    J Clin Endocrinol Metab; 1993 Sep; 77(3):800-4. PubMed ID: 8396580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
    Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
    J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension.
    Duprez DA; Bauwens FR; De Buyzere ML; De Backer TL; Kaufman JM; Van Hoecke J; Vermeulen A; Clement DL
    Am J Cardiol; 1993 Jan; 71(3):17A-20A. PubMed ID: 8421999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
    Chen ZW; Huang KC; Lee JK; Lin LC; Chen CW; Chang YY; Liao CW; Wu VC; Hung CS; Lin YH;
    J Hypertens; 2018 Feb; 36(2):353-360. PubMed ID: 28902663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperaldosteronism suppressible by glucocorticoids. An unusual cause of familial hypertension].
    Pasquet A; Thibaut A; Maiter D; De Plaen JF
    Ann Endocrinol (Paris); 1995; 56(2):149-53. PubMed ID: 7755343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Left ventricular myocardial structure and function in patients with primary aldosteronism].
    Arabidze GG; Chikhladze NM; Sergakova LM; Iarovaia EB
    Ter Arkh; 1999; 71(9):13-9. PubMed ID: 10553618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
    Yamakita N; Yasuda K; Noritake N; Mercado-Asis LB; Murase H; Mune T; Morita H; Miura K
    Acta Endocrinol (Copenh); 1989 Sep; 121(3):334-44. PubMed ID: 2552725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
    Ganguly A; Pratt JH; Weinberger MH; Grim CE; Fineberg NS
    J Clin Endocrinol Metab; 1983 Aug; 57(2):388-92. PubMed ID: 6306041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
    Lee SM; Lightner E; Witte M; Oberfield S; Levine L; New MI
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):251-5. PubMed ID: 6277130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.